Clinical Trial for Zebinix (Eslicarbazepine Acetate) in Healthy Korean and Caucasian Adult
Status:
Completed
Trial end date:
2019-12-16
Target enrollment:
Participant gender:
Summary
A dose randomized, double-blind, placebo controlled, single and multiple dosing,
dose-escalation phase I clinical trial to investigate the safety, tolerability and
pharmacokinetic characteristics of Zebinix (Eslicarbazepine acetate) after oral
administration in healthy Korean and Caucasian adult subjects